The Hong Kong government has appointed healthcare veteran Nisa Leung to the board of the stock exchange, confirming the HKEx’s emphasis on the sector.
She replaces Anita Fung who retires this year.
A managing partner at Qiming Venture Partners, Leung is on the board of Zai Lab, Venus Medtech, CanSino Biologics and Gan & Lee Pharmaceutical.
“We warmly welcome the appointment of Nisa Leung to our board of directors. Her extensive expertise in venture capital, innovation, biotech and healthcare, and her deep knowledge of the mainland China investment market, will be immensely valuable to the board and to HKEx’s future development,” said HKEx chair Laura Cha.
Her two-year term begins at the end of April.